MeadowBrook Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Hold
3,403
0.35% 65
2026
Q1
$409K Buy
3,403
+350
+11% +$40.4K 0.36% 63
2025
Q4
$321K Hold
3,053
0.27% 78
2025
Q3
$256K Hold
3,053
0.22% 91
2025
Q2
$242K Hold
3,053
0.22% 98
2025
Q1
$274K Hold
3,053
0.26% 88
2024
Q4
$304K Hold
3,053
0.27% 84
2024
Q3
$347K Buy
3,053
+53
+2% +$6.3K 0.31% 74
2024
Q2
$371K Sell
3,000
-1,000
-25% -$129K 0.35% 63
2024
Q1
$528K Sell
4,000
-200
-5% -$24.7K 0.49% 49
2023
Q4
$458K Buy
+4,200
New +$436K 0.44% 57

Other funds holding MRK

MeadowBrook Investment Advisors's MRK Position: Q2 2026 in Review

MeadowBrook Investment Advisors held its Merck (MRK) position steady in Q2 2026 at 3,403 shares worth $437K. The position accounts for 0.35% of the portfolio, ranked #65.

MeadowBrook Investment Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $528K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MeadowBrook Investment Advisors held 3,403 shares of Merck worth $437K as of Q2 2026.
  • MeadowBrook Investment Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.35% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #65 holding.
  • MeadowBrook Investment Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's Merck position peaked at $528K in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.